Diabetes and Abdominal Aortic Aneurysm: Is the Protective Effect on AAA Due to Antidiabetic Medications Alone, Due to the Disease Alone, or Both?
- PMID: 38846325
- PMCID: PMC11156236
- DOI: 10.26502/aimr.0169
Diabetes and Abdominal Aortic Aneurysm: Is the Protective Effect on AAA Due to Antidiabetic Medications Alone, Due to the Disease Alone, or Both?
Abstract
Diabetes is a metabolic disease that may result in multiple microvascular and macrovascular diseases. Interestingly, many studies have demonstrated the inverse relationship between diabetes and the development and expansion of abdominal aortic aneurysm (AAA). One hypothesis is that the aortic wall stiffness resulting from hyperglycemia and advanced glycation end products could delay the development and growth of AAA. Other studies have proposed that the concurrent use of antidiabetic medications which promote anti-inflammatory cytokines while hindering pro-inflammatory cytokines may potentially be the reason for this protective effect of diabetes on AAA. Contrastingly, the presence of diabetes has been found to have a negative effect on the outcome of AAA following its repair which may be due to elevated blood glucose negatively affecting the healing process. The current literature has also demonstrated the negative impact of the use of fluoroquinolones on AAA. This comprehensive review critically reviewed and summarized the role of diabetes, anti-diabetes medications and fluoroquinolones on AAA, and on the effect of diabetes and certain anti-diabetes medications on outcomes following its repair.
Keywords: AAA repair; Abdominal aortic aneurysm; Anti-diabetic drugs; Diabetes mellitus; Fluoroquinolones.
Conflict of interest statement
Competing interest: Both authors have read the manuscript and declare no conflict of interest. No writing assistance was utilized in the production of this manuscript.
Figures
Similar articles
-
Double-edged sword of diabetes mellitus for abdominal aortic aneurysm.Front Endocrinol (Lausanne). 2022 Dec 16;13:1095608. doi: 10.3389/fendo.2022.1095608. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589814 Free PMC article. Review.
-
A potential role for glycated cross-links in abdominal aortic aneurysm disease.J Vasc Surg. 2017 May;65(5):1493-1503.e3. doi: 10.1016/j.jvs.2016.04.028. Epub 2016 Sep 10. J Vasc Surg. 2017. PMID: 27624703
-
Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study - protocol for a multicentre cross-sectional study.BMJ Open. 2017 Apr 11;7(4):e012584. doi: 10.1136/bmjopen-2016-012584. BMJ Open. 2017. PMID: 28400456 Free PMC article.
-
Diabetes and abdominal aortic aneurysms.Eur J Vasc Endovasc Surg. 2014 Mar;47(3):243-61. doi: 10.1016/j.ejvs.2013.12.007. Epub 2014 Jan 18. Eur J Vasc Endovasc Surg. 2014. PMID: 24447529 Review.
-
Treatment With Small Molecule Inhibitors of Advanced Glycation End-Products Formation and Advanced Glycation End-Products-Mediated Collagen Cross-Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice.J Am Heart Assoc. 2023 May 16;12(10):e028081. doi: 10.1161/JAHA.122.028081. Epub 2023 May 9. J Am Heart Assoc. 2023. PMID: 37158066 Free PMC article.
References
-
- Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature 576 (2019): 51–60. - PubMed
-
- Mi Mouri, Badireddy M. Hyperglycemia. National Library of Medicine. Published April 24, 2023.
-
- Lucier J, Weinstock RS. Diabetes. Nih.gov. Published March 3, 2023. https://www.ncbi.nlm.nih.gov/books/NBK507713/
-
- Burns C, Francis N. Type 2 Diabetes-Etiology, Epidemiology, Pathogenesis, Treatment. Springer eBooks. Published online January 1 (2023): 1–20.
Grants and funding
LinkOut - more resources
Full Text Sources